Nevertheless, placing a prosthesis requires good training and has procedure costs both of which must be taken into account when considering this procedure 1, 3, 23. Stents were used in the bile ducts of 23 patients 15.1%: ten 11.1% had asymptomatic hyperamylasemia, four 44.4% had pancreatitis, and 9 17.3% were in the normal group. Stents were used more often among patients who developed pancreatitis following ERCP than among other patients. The association was statistically significant with p=0.026.
Se usó el stent en vía biliar en 23 pacientes 15,1% de ellos 10 11,1% con hiperamilasemia asintomática, 444,4% con pancreatitis y 9 17,3% en el grupo normal, observándose en mayor frecuencia en pacientes con presencia de pancreatitis post-CPRE con una relación estadísticamente significativa p = 0,026, al hacer la estimación de riesgo se encontró que este es 5,19 veces mayor en pacientes con pancreatitis post-CPRE OR 5,19; IC 95% 1,27-21,01, considerándose con estos resultados un factor de riesgo independiente para el desarrollo de esta.